IN2014MN01382A - - Google Patents

Info

Publication number
IN2014MN01382A
IN2014MN01382A IN1382MUN2014A IN2014MN01382A IN 2014MN01382 A IN2014MN01382 A IN 2014MN01382A IN 1382MUN2014 A IN1382MUN2014 A IN 1382MUN2014A IN 2014MN01382 A IN2014MN01382 A IN 2014MN01382A
Authority
IN
India
Prior art keywords
simethicone
mannitol
relates
calcium phosphate
present
Prior art date
Application number
Inventor
José Luis Velada
Hiteshkumar Anilkant Doshi
Anjali Rajesh Tendulkar
Vicky Shinde
Original Assignee
Disphar Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Disphar Int Bv filed Critical Disphar Int Bv
Publication of IN2014MN01382A publication Critical patent/IN2014MN01382A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Abstract

The present invention relates to solid pharmaceutical formulations based on simethicone and calcium phosphate and mannitol.
IN1382MUN2014 2011-12-14 2012-12-11 IN2014MN01382A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11193452 2011-12-14
PCT/NL2012/050879 WO2013095111A1 (en) 2011-12-14 2012-12-11 Simethicone formulation

Publications (1)

Publication Number Publication Date
IN2014MN01382A true IN2014MN01382A (en) 2015-04-17

Family

ID=47628413

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1382MUN2014 IN2014MN01382A (en) 2011-12-14 2012-12-11

Country Status (8)

Country Link
US (1) US20150119422A1 (en)
EP (1) EP2790676B1 (en)
AU (1) AU2012327176B2 (en)
BR (1) BR112014014278A2 (en)
CA (1) CA2858821A1 (en)
IN (1) IN2014MN01382A (en)
RU (1) RU2602745C2 (en)
WO (1) WO2013095111A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41620A (en) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S PHARMACEUTICAL COMPOSITION CONSISTING OF SIMETHICONE AND OTILONIUM
US20180311201A1 (en) * 2015-06-12 2018-11-01 Santa Farma ?Laç Sanay? A. ?. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics
MX2016016587A (en) * 2016-12-14 2018-06-13 Rhein Siegfried Sa De Cv Improved composition of lansoprazole and simeticone and method for preparing same.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6793934B1 (en) 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
US7101573B2 (en) 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
WO2007057924A1 (en) 2005-11-21 2007-05-24 Panacea Biotec Ltd Laxative composition on the basis of triphala
WO2008056200A1 (en) * 2006-11-10 2008-05-15 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of simethicone

Also Published As

Publication number Publication date
EP2790676A1 (en) 2014-10-22
US20150119422A1 (en) 2015-04-30
RU2014128604A (en) 2016-02-10
AU2012327176B2 (en) 2015-08-13
EP2790676B1 (en) 2018-01-10
RU2602745C2 (en) 2016-11-20
AU2012327176A1 (en) 2013-07-04
CA2858821A1 (en) 2013-06-27
BR112014014278A2 (en) 2017-06-13
WO2013095111A1 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
JOP20180102B1 (en) Pharmaceutical composition
TR201813877T4 (en) COMPOUNDS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY.
EP2569330A4 (en) Chlorotoxin variants, conjugates, and methods for their use
IN2012DN06714A (en)
MA34058B1 (en) FORMS OF RIFAXIMINE, AND USES THEREOF
PH12014501273A1 (en) Intranasal dexmedetomidine compositions and methods of use thereof
IL227626A0 (en) Il -17 and ifn - gamma inhibitior compounds, compositions comprising the same and uses thereof
JO3755B1 (en) Testosterone formulations
BR112014025041B8 (en) PHARMACEUTICAL COMPOSITION
JO3154B1 (en) Trpv4 antagonists
IN2014DN11078A (en)
IN2014DN07326A (en)
MY165088A (en) Pharmaceutical compositions comprising alisporivir
IN2015DN03132A (en)
MX2014008390A (en) Romidepsin formulations and uses thereof.
IN2014MN01382A (en)
UA117567C2 (en) Galactagogue compositions based on phosphatidylserine
MX2014006201A (en) Imatinib solid dosage forms reconstituted just before use.
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
MX2023003000A (en) Modified release formulations of viloxazine.
MX363558B (en) Pharmaceutical compositions comprising flurbiprofen.
MX2013008559A (en) Leptin derivatives.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
TN2013000218A1 (en) Pharmaceutical compositions comprising alisporivir
UA105703C2 (en) 7-bromo-5-phenyl-3-arylamino-1,2-dihydro-3h-1,4-benzdiazepin-2-ones as analgetic agents